Kreysing J, Bohne W, Bösenberg C, Marchesini S, Turpin J C, Baumann N, von Figura K, Gieselmann V
Department of Biochemistry II, Georg August Universität, Göttingen, Germany.
Am J Hum Genet. 1993 Aug;53(2):339-46.
We identified a patient suffering from late-infantile metachromatic leukodystrophy (MLD) who has a residual arylsulfatase A (ARSA) activity of about 10%. Fibroblasts of the patient show significant sulfatide degradation activity exceeding that of adult MLD patients. Analysis of the ARSA gene in this patient revealed heterozygosity for two new mutant alleles: in one allele, deletion of C 447 in exon 2 leads to a frameshift and to a premature stop codon at amino acid position 105; in the second allele, a G-->A transition in exon 5 causes a Gly309-->Ser substitution. Transient expression of the mutant Ser309-ARSA resulted in only 13% enzyme activity of that observed in cells expressing normal ARSA. The mutant ARSA is correctly targeted to the lysosomes but is unstable. These findings are in contrast to previous results showing that the late-infantile type of MLD is always associated with the complete absence of ARSA activity. The expression of the mutant ARSA protein may be influenced by particular features of oligodendrocytes, such that the level of mutant enzyme is lower in these cells than in others.
我们鉴定出一名患有晚期婴儿型异染性脑白质营养不良(MLD)的患者,其芳基硫酸酯酶A(ARSA)的残余活性约为10%。该患者的成纤维细胞表现出显著的硫脂降解活性,超过了成年MLD患者。对该患者ARSA基因的分析揭示了两个新突变等位基因的杂合性:在一个等位基因中,外显子2中C447的缺失导致移码,并在氨基酸位置105处产生一个过早的终止密码子;在第二个等位基因中,外显子5中的G→A转换导致Gly309→Ser取代。突变型Ser309-ARSA的瞬时表达导致的酶活性仅为表达正常ARSA的细胞中所观察到的13%。突变型ARSA正确地靶向溶酶体,但不稳定。这些发现与先前的结果形成对比,先前结果表明晚期婴儿型MLD总是与ARSA活性完全缺失相关。突变型ARSA蛋白的表达可能受少突胶质细胞的特定特征影响,使得这些细胞中突变酶的水平低于其他细胞。